GvHD Hub
By Scientific Education Support
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Scientific Education Support
Category: Education
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 35
Description
The GvHD Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in GvHD. Our aim is to enhance knowledge in GvHD, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management.
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
How I treat GvHD in children using ECP: Insights from a case study
|
Aug 06, 2026 |
|
Symposium | Impact of clinical manifestations on treatment selection in SR-cGvHD
|
Jul 17, 2026 |
|
Symposium | Emerging treatment strategies for SR-cGvHD
|
Jul 17, 2026 |
|
Symposium | Panel discussion: Shifting the treatment paradigm in cGvHD
|
Jul 17, 2026 |
|
Symposium | Current treatment options for SR-cGvHD
|
Jul 10, 2026 |
|
How do you approach later-line sequencing in cGvHD in your clinical practice?
|
Jul 01, 2026 |
|
How might emerging therapies and combination approaches reshape sequencing strategies in cGvHD?
|
Jul 01, 2026 |
|
What factors drive your decision to switch from first- to second-line therapy for cGvHD?
|
Jun 30, 2026 |
|
Symposium | Patient’s perspective: My journey with GvHD
|
May 22, 2026 |
|
Symposium | Physician’s perspective: How I treat GvHD with ECP
|
May 18, 2026 |
|
Symposium | The role of nurses within the multidisciplinary GvHD care team
|
May 14, 2026 |
|
What are the treatment options for chronic GvHD-associated fibrosis?
|
Mar 05, 2026 |
|
MSCs: From clinical trials to clinical practice
|
Feb 26, 2026 |
|
Symposium | Early treatment strategies for SR-GvHD
|
Dec 05, 2025 |
|
Symposium | Quality of life and symptoms in cGvHD
|
Dec 03, 2025 |
|
What are the treatment options for ruxolitinib-refractory acute GvHD?
|
Dec 01, 2025 |
|
Symposium | The importance of real-world data in allogeneic stem cell transplantation: A focus on cGvHD
|
Nov 27, 2025 |
|
What are the current treatment options for steroid-refractory chronic GvHD?
|
Nov 14, 2025 |
|
What are the major challenges in the treatment of SR-GvHD, and how can clinicians overcome these?
|
Oct 16, 2025 |
|
How can measurement of QoL and use of PROs be improved in cGvHD?
|
Jul 10, 2025 |
|
ECP + ruxolitinib to prevent cGvHD in patients with SRaGvHD
|
Jul 02, 2025 |
|
How does real-world evidence complement RCTs, and why is it important for small patient populations?
|
May 08, 2025 |
|
Key insights into MSCs for aGvHD – the current clinical trial landscape
|
Apr 30, 2025 |
|
Future perspectives of ECP for GvHD treatment
|
Aug 19, 2024 |
|
Symposium | ECP for chronic GvHD: Patient eligibility, treatment optimization, and follow-up
|
Aug 09, 2024 |
|
Symposium | Early intervention and use of ECP combinations in cGvHD
|
Aug 09, 2024 |
|
Symposium | The long-term burden of cGvHD
|
Aug 09, 2024 |
|
Symposium | A brief overview and history of ECP
|
Aug 09, 2024 |
|
What should supportive care look like for patients with chronic GvHD?
|
Jan 02, 2023 |
|
How would you treat aGvHD in your clinic (an EU perspective)?
|
May 11, 2022 |
|
What should supportive care look like for patients with GvHD? What role does physical activity play in these patients?
|
Apr 13, 2022 |
|
How do we stratify risk in patients with GvHD?
|
Apr 11, 2022 |
|
What's the latest in treatment of steroid-refractory acute GvHD at ASH 2021?
|
Dec 23, 2021 |
|
How can patient-reported QoL change our view on unmet needs in GvHD?
|
Apr 07, 2021 |
|
How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease
|
Jun 29, 2020 |